Sort
53,477 grants matching “addiction”
Novel Dopamine D3 Receptor Ligands
$1,034,943Amy Hauck Newman · National Institute On Drug Abuse · Z01 · FY2008 · DA
Affective and Conative Changes in Alcoholism
$1,034,684Marlene Oscar Berman · Boston University Medical Campus · R01 · FY2012 · AA
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics
$1,034,659Stephanie K Florio · Anagin · U44 · FY2023 · NS
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?
$1,033,654Evan D Morris · Yale University · R01 · FY2020 · DA
Presynaptic Mechanisms of Neural Plasticity
$1,033,369Robert H Edwards · University Of California, San Francisco · P01 · FY2013 · DA
Synthesis of peripherally active CB1 agonists as analgesics
$1,033,359Susruta Majumdar · St. Louis College Of Pharmacy · R34 · FY2021 · NS
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?
$1,033,116Evan D Morris · Yale University · R01 · FY2023 · DA
Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
$1,032,518Thomas Kerr · University Of British Columbia · U01 · FY2016 · DA
Alliance to Disseminate Addiction Prevention and Treatment (ADAPT): A Statewide Learning Health System to Reduce Substance Use among Justice-Involved Youth in Rural Communities.
$1,032,475Matthew Aalsma · Indiana University Indianapolis · UG1 · FY2019 · DA
ORWH: SCOR on Sex and Gender Factors Afecting Women's Health
$1,031,794Rajita Sinha · Yale University · P50 · FY2008 · DA
NATIONAL NEUROLOGICAL AIDS BANK
$1,031,572University Of California Los Angeles · R24 · FY2000 · NS
VACCINATION FOR TREATMENT OF NICTOTINE DEPENDENCE
$1,031,569Nabi Biopharmaceuticals · U19 · FY2002 · DA
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)
$1,031,340Meredith C. B. Adams · Wake Forest University Health Sciences · R24 · FY2022 · DA
Hypothalamic neuronal circuits controlling goal-directed behaviors
$1,031,222Yexica Aponte Moreno · National Institute On Drug Abuse · ZIA · FY2013 · DA
Reversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE)
$1,031,158Xiao Zang · University Of Minnesota · R33 · FY2025 · DA
The National Drug Abuse Treatment Clinical Trials Network
$1,031,146Roger D. Weiss · Mclean Hospital · UG1 · FY2018 · DA
An innovative, trauma-informed approach for reducing overdose risk among women re-entering the community from prison
$1,030,973Michele Staton · University Of Kentucky · R33 · FY2025 · DA
Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: Mice
$1,030,087George R Uhl · National Institute On Drug Abuse · ZIA · FY2011 · DA
The National Drug Abuse Treatment Clinical Trials Network (U10)
$1,029,109Roger D. Weiss · Mclean Hospital · U10 · FY2014 · DA
Developmemt of Novel Treatments for Nicotine Addiction
$1,029,082University Of Kentucky · U19 · FY2003 · DA
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$1,028,940Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)
$1,028,772Karen L Cropsey · University Of Alabama At Birmingham · P01 · FY2025 · AA
Non-oncogene addiction in cancer cells
$1,028,502Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Sex and Gender Influences on Addiction and Health: A Developmental Perspective
$1,028,119Emmalee S. Bandstra · University Of Miami School Of Medicine · P50 · FY2007 · DA
Neuroimaging of Brain Circuits and Neurogenetic Mechanisms in Normal Cognition
$1,028,049Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2010 · MH